top of page
Contact Us

Core concentration

Biostatistical Consulting

Core service

Approval - Grade Results

abstract knee running
blue abstract image

Design

Specializing in designing clinical trials to secure FDA approval of a drug or medical device.

BSC® White Logo

Analyze

Delivering precision, auditability, and regulatory confidence.

BSC® White Logo

Advance

Analyzing ongoing clinical trial submissions and/or after their completion.

BSC® White Logo

BSC® Services

Experienced to handle it all. Dedicated to never hand you off.

Hero brain

Decades of leadership.

Proven regulatory outcomes.

Our work focuses on defensible analyses, clear communication, and outcomes that stand up to regulatory scrutiny.

BSC® supports sponsors across the full clinical development lifecycle with rigorous, regulator-facing biostatistics.

BSC® Credibility

Proven Regulatory Expertise in

Designing, Analyzing, Advancing Clinical Trials

BSC® supports sponsors across the full clinical development lifecycle with rigorous, regulator-facing biostatistics.

We partner with Sponsors to design robust trials, deliver submission-ready analyses, and advance programs through FDA and regulatory review with clarity and confidence.

36+
years

FDA facing Leadership.

500+
clients

Reputation earned through success in high stakes situations.

800+
projects

Design. Analyze. Advance.®

blue abstract knee image
BSC® White Logo

We Solve Problems.

BSC® Therapy Areas

Clinical Depth Across Specialties.

BSC® Differentiator

What Sets us Apart

Submission Grade Experience

Regulatory-first biostatistics

Support built specifically for FDA-facing programs, from early feasibility through submission and post-market requirements.

Direct communication, faster turn around

Our biostatisticians write the SAP and run the analysis. One person owns both — no separate programmer, no project manager in between.

Versatile Solutions

Engage us for a focused analysis or a full submission, We size the work to the problem.

Proven FDA Experience

Hands-On Experience with FDA Pathways, statistical reviews, and regular interactions, reducing risk and rework.

abstract human upper body

Biomedical Statistical Consulting® (BSC®) is a specialized biostatistics regulatory consulting firm supporting life-science companies from early study design through FDA approval.

 

We work with teams developing medical devices, diagnostics, and therapeutics in highly regulated environments, providing statistical rigor and regulatory clarity where scrutiny is high and decisions matter.

 

BSC® combines deep biostatistical expertise with hands-on FDA experience. Engagements are led by in-house experts who work directly with clients to reduce risk, strengthen submissions, and support successful regulatory outcomes.

BSC® Solutions

Whatever stage you're in, we've been there.

Starting a Trial

The decisions you make before enrolling the first subject define everything that follows.

Running a Study

Enrollment is just the beginning. Keeping it on track is where the real work starts.

Breaking New Ground

There's no predicate to reference.

Stuck or In Trouble

If you’re on this page, something has gone wrong, and you need help. Let's fix it.

Preparing to Submit

Your data is in. What happens next determines whether it's enough.

WHAT CLIENTS SAY

“They listen the first time. I’ve never had to go back and respell out what I needed." 


”They work to understand the problem and leverage the information that is already there.”

Former FDA Regulator

WHAT CLIENTS SAY

"Battle ground tested."


"There is nothing that David and team haven’t seen over the years – the good, bad, and ugly.”

Vice President, Clinical Operations

WHAT CLIENTS SAY

"Get stuff done when you have to do something no one else has done before."


"They aren’t afraid to tackle difficult scenarios in compressed timelines."

CEO, Medical Device Company

BSC® Partners

Trusted by Investors Globally.

BSC® Insights

Get Regulatory Insights

from BSC® 

September 24, 2026

Understanding Medical Device Regulation Compliance

FDA Regulatory Strategy

September 24, 2026

The Strategic Edge in FDA Submissions

FDA Regulatory Strategy

September 24, 2026

Randomization and Kit Lists

Trial Design & Methodology

BSC® Security

Robust data security and confidentiality
across sensitive, FDA-regulated clinical and regulatory data.

For more information visit our trust center

Trust Center

GDPR

SOC-2
in progress

bottom of page